Jinrong Zhao

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Epstein Barr Virus

Diffuse Large B Cell Lymphoma

Top Venues

Blood cancer journal

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Dao-Bin Zhou
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Dao-Bin Zhou
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Dao-Bin Zhou
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Dao-Bin Zhou
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Dao-Bin Zhou
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Jinrong Zhao, Yan Zhang, Wei Wang, Wei Zhang, Dao-Bin Zhou
Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients. Journal of oncology 2022 (2022)